Role and Association of Inflammatory and Apoptotic Caspases in Renal Tubulointerstitial Fibrosis

Kidney and Blood Pressure Research

Volumn 41, Issue 5, 2016, Pages 643-653

  Ke, You ^a   Tang, Hui ^a   Ye, Chen ^a   Lei, Chun Tao ^a   Wang, Yu Mei ^a   Su, Hua ^a   Zhang, Chun ^a   Jiang, Hua Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Caspase 1; Caspase 7; Renal Tubulointerstitial Fibrosis; TGF 1

Indexed keywords

CASPASE 7; COLLAGEN TYPE 3; FIBRONECTIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; CASP7 PROTEIN, MOUSE; CASPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL CULTURE; CELL STIMULATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE SILENCING; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL TUBULOINTERSTITIAL FIBROSIS; SIGNAL TRANSDUCTION; STAINING; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; ENZYMOLOGY; FIBROSIS; HUMAN; INFLAMMATION; KIDNEY TUBULE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASE 1; CASPASE 7; CASPASES; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; FIBROSIS; HUMANS; INFLAMMATION; KIDNEY TUBULES; MICE; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84988632509     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000447933     Document Type: Article

References (42)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - A position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-259.
2. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L: Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010;55:S1-420, A426-427.
3. Zeisberg M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010;21:1819-1834.
4. Galluzzi L, Lopez-Soto A, Kumar S, Kroemer G: Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity 2016;44:221-231.
5. Li J, Yuan J: Caspases in apoptosis and beyond. Oncogene 2008;27:6194-6206.
6. Ahmad M, Srinivasula SM, Hegde R, Mukattash R, Fernandes-Alnemri T, Alnemri ES: Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res 1998;58:5201-5205.
7. Martinon F, Tschopp J: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574.
8. Stennicke HR, Salvesen GS: Biochemical characteristics of caspases-3,-6,-7, and-8. J Biol Chem 1997;272:25719-25723.
9. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al. : A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992;356:768-774.
10. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPSinduced IFN-gamma production. Nature 1997;386:619-623.
11. Schroder K, Tschopp J: The inflammasomes. Cell 2010;140:821-832.
12. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y: Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 2001;107:399-407.
13. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241.
14. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM, Gallo RL: NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009;284:12762-12771.
15. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Grone HJ, Schaefer L: Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009;284:24035-24048.
16. Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edelstein CL: Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 2004;66:2202-2213.
17. Anders HJ, Muruve DA: The inflammasomes in kidney disease. J Am Soc Nephrol 2011;22:1007-1018.
18. Gong W, Mao S, Yu J, Song J, Jia Z, Huang S, Zhang A: NLRP3 Deletion Protects against Renal Fibrosis and Attenuates Mitochondrial Abnormality in Mouse with 5/6 Nephrectomy. Am J Physiol Renal Physiol 2016;310:F1081-F1088.
19. Lamkanfi M, Kanneganti TD, Van Damme P, Vanden Berghe T, Vanoverberghe I, Vandekerckhove J, Vandenabeele P, Gevaert K, Nunez G: Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics 2008;7:2350-2363.
20. Van de Craen M, Declercq W, Van den brande I, Fiers W, Vandenabeele P: The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ 1999;6:1117-1124.
21. Malireddi RK, Ippagunta S, Lamkanfi M, Kanneganti TD: Cutting edge: proteolytic inactivation of poly(ADPribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes. J Immunol 2010;185:3127-3130.
22. Lakhani SA, Masud A, Kuida K, Porter GA Jr., Booth CJ, Mehal WZ, Inayat I, Flavell RA: Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006;311:847-851.
23. Leonard JR, Klocke BJ, D'Sa C, Flavell RA, Roth KA: Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice. J Neuropathol Exp Neurol 2002;61:673-677.
24. Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP: Transcriptional activation of caspase-6 and-7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 2008;15:530-544.
25. Sakairi T, Abe Y, Kopp JB: TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes. Nephrol Dial Transplant 2011;26:2746-2752.
26. He Y, Huang C, Sun X, Long XR, Lv XW, Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012;24:1923-1930.
27. Abais JM, Xia M, Li G, Chen Y, Conley SM, Gehr TW, Boini KM, Li PL: Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia. J Biol Chem 2014;289:27159-27168.
28. Goncalves RG, Gabrich L, Rosario A Jr., Takiya CM, Ferreira ML, Chiarini LB, Persechini PM, Coutinho-Silva R, Leite M, Jr. : The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int 2006;70:1599-1606.
29. Harris RC, Neilson EG: Toward a unified theory of renal progression. Annu Rev Med 2006;57:365-380.
30. Sutariya B, Jhonsa D, Saraf MN: TGF-beta: the connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol 2016;38:39-49.
31. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008;118:3522-3530.
32. Segelmark M, Hellmark T: Autoimmune kidney diseases. Autoimmun Rev 2010;9:A366-371.
33. Park JS, Kim S, Jo CH, Oh IH, Kim GH: Effects of dietary salt restriction on renal progression and interstitial fibrosis in adriamycin nephrosis. Kidney Blood Press Res 2014;39:86-96.
34. Tschopp J, Schroder K: NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 2010;10:210-215.
35. Cao Y, Fei D, Chen M, Sun M, Xu J, Kang K, Jiang L, Zhao M: Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury. FEBS J 2015;282:3799-3807.
36. Gao P, Meng XF, Su H, He FF, Chen S, Tang H, Tian XJ, Fan D, Wang YM, Liu JS, Zhu ZH, Zhang C: Thioredoxininteracting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta 2014;1843:2448-2460.
37. Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA: The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 2010;21:1732-1744.
38. Akhter A, Gavrilin MA, Frantz L, Washington S, Ditty C, Limoli D, Day C, Sarkar A, Newland C, Butchar J, Marsh CB, Wewers MD, Tridandapani S, Kanneganti TD, Amer AO: Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog 2009;5:e1000361.
39. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, Martin SJ: Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 2008;105:12815-12819.
40. Van Damme P, Maurer-Stroh S, Plasman K, Van Durme J, Colaert N, Timmerman E, De Bock PJ, Goethals M, Rousseau F, Schymkowitz J, Vandekerckhove J, Gevaert K: Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs. Mol Cell Proteomics 2009;8:258-272.
41. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003;112:1486-1494.
42. Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010;21:212-222.